Glenmede Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.9M | Sell |
221,975
-27,375
| -11% | -$3.83M | 0.15% | 122 |
|
|
2025
Q4 | $30.6M | Buy |
+249,350
| New | +$30.3M | 0.15% | 126 |
|
|
2025
Q1 | $30.5M | Buy |
271,770
+8,394
| +3% | +$866K | 0.16% | 124 |
|
|
2024
Q4 | $24.3M | Sell |
263,376
-28,672
| -10% | -$2.58M | 0.12% | 150 |
|
|
2024
Q3 | $24.5M | Sell |
292,048
-34,711
| -11% | -$2.65M | 0.12% | 171 |
|
|
2024
Q2 | $22.4M | Sell |
326,759
-33,427
| -9% | -$2.23M | 0.11% | 176 |
|
|
2024
Q1 | $26.4M | Sell |
360,186
-13,090
| -4% | -$1.01M | 0.13% | 158 |
|
|
2023
Q4 | $30.2M | Buy |
373,276
+8,296
| +2% | +$646K | 0.16% | 133 |
|
|
2023
Q3 | $27.4M | Buy |
364,980
+39,619
| +12% | +$3.05M | 0.16% | 138 |
|
|
2023
Q2 | $27M | Sell |
325,361
-243
| -0.1% | -$19.4K | 0.15% | 154 |
|
|
2023
Q1 | $27M | Buy |
325,604
+55,315
| +20% | +$4.58M | 0.15% | 154 |
|
|
2022
Q4 | $23.2M | Buy |
270,289
+103,696
| +62% | +$8.21M | 0.14% | 176 |
|
|
2022
Q3 | $10.3M | Buy |
166,593
+1,098
| +0.7% | +$69.2K | 0.06% | 315 |
|
|
2022
Q2 | $10.2M | Sell |
165,495
-40,886
| -20% | -$2.53M | 0.06% | 343 |
|
|
2022
Q1 | $12.3M | Buy |
206,381
+10,215
| +5% | +$653K | 0.06% | 346 |
|
|
2021
Q4 | $14.2M | Sell |
196,166
-11,219
| -5% | -$773K | 0.07% | 328 |
|
|
2021
Q3 | $14.5M | Sell |
207,385
-15,551
| -7% | -$1.09M | 0.08% | 296 |
|
|
2021
Q2 | $15.4M | Sell |
222,936
-45,066
| -17% | -$3.01M | 0.08% | 275 |
|
|
2021
Q1 | $17.3M | Sell |
268,002
-268,308
| -50% | -$17.3M | 0.09% | 241 |
|
|
2020
Q4 | $31.2M | Sell |
536,310
-146,992
| -22% | -$8.87M | 0.17% | 149 |
|
|
2020
Q3 | $43.2M | Sell |
683,302
-156,876
| -19% | -$10.9M | 0.26% | 103 |
|
|
2020
Q2 | $64.6M | Buy |
840,178
+83,410
| +11% | +$6.39M | 0.4% | 67 |
|
|
2020
Q1 | $49.2M | Hold |
756,768
| – | – | 0.22% | 123 |
|
|
2019
Q4 | $49.2M | Sell |
756,768
-65,777
| -8% | -$4.28M | 0.22% | 123 |
|
|
2019
Q3 | $52.1K | Sell |
822,545
-362,065
| -31% | -$23.7M | 0.24% | 117 |
|
|
2019
Q2 | $80K | Buy |
1,184,610
+451,770
| +62% | +$29.7M | 0.35% | 68 |
|
|
2019
Q1 | $47.6K | Sell |
732,840
-424,686
| -37% | -$28.2M | 0.22% | 135 |
|
|
2018
Q4 | $72.4K | Buy |
1,157,526
+148,334
| +15% | +$10.4M | 0.35% | 67 |
|
|
2018
Q3 | $77.9M | Buy |
1,009,192
+329,998
| +49% | +$24.9M | 0.31% | 72 |
|
|
2018
Q2 | $48.1M | Buy |
679,194
+31,937
| +5% | +$2.26M | 0.21% | 145 |
|
|
2018
Q1 | $46.4M | Hold |
647,257
| – | – | 0.19% | 157 |
|
|
2017
Q4 | $46.4M | Buy |
647,257
+23,751
| +4% | +$1.8M | 0.19% | 157 |
|
|
2017
Q3 | $50.5M | Buy |
623,506
+187,362
| +43% | +$14.3M | 0.22% | 131 |
|
|
2017
Q2 | $29.6M | Hold |
436,144
| – | – | 0.14% | 225 |
|
|
2017
Q1 | $29.6M | Buy |
436,144
+76,491
| +21% | +$5.38M | 0.14% | 225 |
|
|
2016
Q4 | $25.8M | Sell |
359,653
-30,495
| -8% | -$2.27M | 0.14% | 247 |
|
|
2016
Q3 | $30.9M | Sell |
390,148
-737,118
| -65% | -$59.9M | 0.17% | 199 |
|
|
2016
Q2 | $94M | Buy |
1,127,266
+175,892
| +18% | +$15.6M | 0.57% | 24 |
|
|
2016
Q1 | $87.4M | Buy |
951,374
+168,670
| +22% | +$15.2M | 0.57% | 31 |
|
|
2015
Q4 | $79.2M | Buy |
782,704
+119,963
| +18% | +$12.5M | 0.54% | 31 |
|
|
2015
Q3 | $65.1M | Buy |
662,741
+56,842
| +9% | +$6.31M | 0.48% | 39 |
|
|
2015
Q2 | $70.9M | Buy |
605,899
+20,103
| +3% | +$2.2M | 0.51% | 35 |
|
|
2015
Q1 | $57.5M | Buy |
585,796
+122,410
| +26% | +$12.4M | 0.42% | 45 |
|
|
2014
Q4 | $43.7M | Buy |
463,386
+179,866
| +63% | +$18.6M | 0.34% | 62 |
|
|
2014
Q3 | $30.2M | Buy |
283,520
+112,959
| +66% | +$11.1M | 0.26% | 89 |
|
|
2014
Q2 | $14.1M | Buy |
170,561
+3,866
| +2% | +$301K | 0.13% | 239 |
|
|
2014
Q1 | $11.8M | Buy |
166,695
+40,830
| +32% | +$3.2M | 0.11% | 263 |
|
|
2013
Q4 | $9.45M | Sell |
125,865
-27,226
| -18% | -$1.9M | 0.1% | 278 |
|
|
2013
Q3 | $9.62M | Buy |
153,091
+30,148
| +25% | +$1.8M | 0.11% | 234 |
|
|
2013
Q2 | $6.3M | Buy |
+122,943
| New | +$6.41M | 0.08% | 282 |
|
Other funds holding GILD
VCM
VPM
Glenmede Trust's GILD Position: Q1 2026 in Review
Glenmede Trust reduced its Gilead Sciences (GILD) stake by 11% in Q1 2026, selling an estimated $3.83M and leaving 221,975 shares worth $30.9M. The position accounts for 0.15% of the portfolio, ranked #122.
Glenmede Trust first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $94M in Q2 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Glenmede Trust held 221,975 shares of Gilead Sciences worth $30.9M as of Q1 2026.
- Glenmede Trust sold 27,375 Gilead Sciences shares in Q1 2026, an estimated $3.83M.
- Gilead Sciences made up 0.15% of Glenmede Trust's portfolio in Q1 2026, its #122 holding.
- Glenmede Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's Gilead Sciences position peaked at $94M in Q2 2016.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.